[HTML][HTML] Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: A systematic review and meta-analysis
KF Müskens, CA Lindemans, R Dandis, S Nierkens… - Blood Reviews, 2023 - Elsevier
Poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation (HCT) is a
serious complication with high morbidity and mortality. The reported incidence of PGF, its …
serious complication with high morbidity and mortality. The reported incidence of PGF, its …
Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
X Zhang, X Zhao, S Chen, M Hao, L Zhang… - Bone Marrow …, 2024 - nature.com
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers rapid hematopoietic
and immune reconstitution for aplastic anemia (AA). As a non-malignant disorder …
and immune reconstitution for aplastic anemia (AA). As a non-malignant disorder …
Evaluation of the precision of kinetic stem cell (KSC) counting for specific quantification of human mesenchymal stem cells in heterogeneous tissue cell preparations
Kinetic stem cell (KSC) counting is a recently introduced first technology for quantifying
tissue stem cells in vertebrate organ and tissue cell preparations. Previously, effective …
tissue stem cells in vertebrate organ and tissue cell preparations. Previously, effective …
Unmanipulated haploidentical haematopoietic cell transplantation with radiation‐free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese …
L Xu, Y Lu, S Hu, C Li, Y Tang, H Wang… - British Journal of …, 2022 - Wiley Online Library
Haematopoietic cell transplantation (HCT) is the only curative treatment for haematological
complications in patients with Fanconi anaemia (FA). Haploidentical (haplo‐) HCT is a …
complications in patients with Fanconi anaemia (FA). Haploidentical (haplo‐) HCT is a …
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping
X Wu, X Ma, T Song, J Liu, Y Sun, D Wu - Annals of Hematology, 2024 - Springer
Cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell
transplantation (allo-HSCT) remains a challenging problem, and the impact on the risk of …
transplantation (allo-HSCT) remains a challenging problem, and the impact on the risk of …
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for …
A Kotb, H Alzahrani, A Alahmari, SO Ahmed, S Alhayli… - Cytotherapy, 2023 - Elsevier
Background aims Graft failure after allogeneic transplant for aplastic anemia is problematic.
The risk of graft failure depends on multiple variables, including the preparative regimen …
The risk of graft failure depends on multiple variables, including the preparative regimen …
儿童再生障碍性贫血造血干细胞移植相关并发症
徐佳伟， 金润铭 - 临床儿科杂志, 2023 - jcp.xinhuamed.com.cn
再生障碍性贫血(AA) 是一种骨髓造血衰竭性疾病, 主要表现为骨髓造血功能低下,
全血细胞减少和贫血/出血/感染征候群. 异基因造血干细胞移植是治疗重型AA 的重要手段 …
全血细胞减少和贫血/出血/感染征候群. 异基因造血干细胞移植是治疗重型AA 的重要手段 …
[HTML][HTML] Salvage second allogeneic stem cell transplantation for primary and secondary graft failure in adult patients
TA Rudakova, ES Yakimenko, NP Volkov… - Cellular Therapy and …, 2023 - cyberleninka.ru
We have evaluated clinical outcomes in 49 patients who received unmanipulated allogeneic
hematopoietic stem cell transplantation (allo-HSCT) as a salvage treatment for primary …
hematopoietic stem cell transplantation (allo-HSCT) as a salvage treatment for primary …
[引用][C] T‐cell‐replete retransplantation in children with severe aplastic anemia who developed late graft failure
Y Gunji, H Yagasaki, K Kanezawa… - Pediatric Blood & …, 2024 - Wiley Online Library